biosimilar biological product
(3) The term “biosimilar biological product” means a specific strength of a biological product in final dosage form for which a biosimilar biological product application has been approved.
Source
21 USC § 379j-51(3)
Scoping language
For purposes of this subpart
Is this correct?
or